Home » Newsletters » BioWorld Science

BioWorld Science

June 27, 2005

View Archived Issues

WT1-peptide vaccination proven effective in acute myeloid leukemia

Good results reported for deferasirox in transfusion-related iron overload

MedImmune and Avalon team up to treat inflammatory disease

Animal studies to test CytoGenix synthetic DNA vaccine against smallpox

Phase II data on MBX-102 reports efficacy without the side effects of weight gain and edema

Clinical analysis of Technosphere Insulin

Antidiabetic activity of SGL-0010 described

Long-term benefits of atorvastatin in patients with type 2 diabetes

Update on the antitumor effects of lenalidomide in hematological malignancies

Enrollment open in phase I/II study of HIV integrase inhibitor GS-9137

Enrollment completed in phase III PROTECT study of Provenge

Iclaprim shows potential for pneumonia in phase I study

IND-enabling animal safety studies for CT-322

Indaflex launched in Mexico

Encouraging interim analysis for phase II trial of ACP-103

BioLineRx inlicenses new compounds

BI-201 begins phase I/IIa studies for HIV

Positive phase II findings for TheraCLEC

Allon seeks clearance for clinical trials of AL-208

PDL sublicenses antibody-drug conjugate rights to Genentech

Antigen Express and Stallergenes partner on novel allergy therapy

Genelabs updates Prestara developmental status

Novel androgen receptor agonists emerge from Schering AG R&D

Novel agents for AIDS imparted by ViroChem

Novel analgesic agents claimed in recent patent literature

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....